Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary systemic therapy for breast cancer.

A P Forrest1, E D Anderson, D Gaskill

  • 1University of Edinburgh, Department of Surgery, Royal Infirmary of Edinburgh.

British Medical Bulletin
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary 17-Ketosteroids and their Fractions in Women with Breast Cancer Treated by Endocrine Surgery.

British journal of cancer·2011
Same author

Development of DNA vaccines for salmonid fish.

Methods in molecular medicine·2011
Same author

A controlled trial of conservative treatment for early breast cancer.

Proceedings of the Royal Society of Medicine·2010
Same author

Veno-arterial extracorporeal membrane oxygenation for high-risk cardiac catheterisation procedures.

Heart, lung & circulation·2010
Same author

The Malnutrition Screening Tool is a useful tool for identifying malnutrition risk in residential aged care.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2009
Same author

Management of Pituitary Tumours.

Proceedings of the Royal Society of Medicine·2009

Primary systemic chemotherapy is an effective treatment for operable breast cancer, particularly for elderly patients. This approach improves outcomes for those with locally advanced disease without distant metastases.

Area of Science:

  • Oncology
  • Medical treatment

Background:

  • Primary systemic chemotherapy (PSC) was developed to treat locally advanced, operable breast cancer without distant metastases.
  • Historically, its application has focused on improving patient prognosis in such cases.

Purpose of the Study:

  • To evaluate the efficacy of primary systemic chemotherapy in elderly patients with operable breast cancer.
  • To determine if PSC is a viable treatment option for this demographic.

Main Methods:

  • Review of clinical trials investigating PSC for operable breast cancer.
  • Analysis of treatment outcomes in elderly patient cohorts receiving PSC.

Main Results:

  • Clinical trials demonstrate that PSC is a beneficial treatment for operable breast cancer.

Related Experiment Videos

  • Evidence suggests PSC is also a worthwhile approach for elderly patients with primary breast cancer.

    • Conclusions:

    • Primary systemic chemotherapy is a valuable treatment modality for operable breast cancer.
    • The approach shows promise and efficacy in the elderly population, warranting further consideration.